Ionising radiation exposure-induced regulation of selected biomarkers and their impact in cancer and treatment

dc.contributor.authorMzizi, Yonwaba
dc.contributor.authorMbambara, Saidon
dc.contributor.authorMoetlhoa, Boitumelo
dc.contributor.authorMahapane, Johncy
dc.contributor.authorMdanda, Sipho
dc.contributor.authorSathekge, Mike Machaba
dc.contributor.authorKgatle, Mankgopo
dc.date.accessioned2025-02-12T05:50:12Z
dc.date.available2025-02-12T05:50:12Z
dc.date.issued2024-10
dc.description.abstractIonising radiation (IR) is a form of energy that travels as electromagnetic waves or particles. While it is vital in medical and occupational health settings, IR can also damage DNA, leading to mutations, chromosomal aberrations, and transcriptional changes that disrupt the functions of certain cell regulators, genes, and transcription factors. These disruptions can alter functions critical for cancer development, progression, and treatment response. Additionally, IR can affect various cellular proteins and their regulators within different cell signalling pathways, resulting in physiological changes that may promote cancer development, progression, and resistance to treatment. Understanding these impacts is crucial for developing strategies to mitigate the harmful effects of IR exposure and improve cancer treatment outcomes. This review focuses on specific genes and protein biomarkers regulated in response to chronic IR exposure, and how their regulation impacts disease onset, progression, and treatment response.en_US
dc.description.departmentNuclear Medicineen_US
dc.description.departmentRadiographyen_US
dc.description.departmentSchool of Health Systems and Public Health (SHSPH)en_US
dc.description.sdgSDG-03:Good heatlh and well-beingen_US
dc.description.sdgSDG-09: Industry, innovation and infrastructureen_US
dc.description.urihttps://www.frontiersin.org/journals/nuclear-medicineen_US
dc.identifier.citationMzizi, Y., Mbambara, S., Moetlhoa, B., Mahapane, J., Mdanda, S., Sathekge, M.& Kgatle, M. (2024) Ionising radiation exposure-induced regulation of selected biomarkers and their impact in cancer and treatment. Frontiers in Nuclear Medicine 4:1469897. doi: 10.3389/fnume.2024.1469897.en_US
dc.identifier.issn2673-8880 (online)
dc.identifier.other10.3389/fnume.2024.1469897
dc.identifier.urihttp://hdl.handle.net/2263/100756
dc.language.isoenen_US
dc.publisherFrontiers Mediaen_US
dc.rights© 2024 Mzizi, Mbambara, Moetlhoa, Mahapane, Mdanda, Sathekge and Kgatle. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY).en_US
dc.subjectAlterationen_US
dc.subjectBiomarkersen_US
dc.subjectCanceren_US
dc.subjectGenesen_US
dc.subjectIonising radiationen_US
dc.subjectProteinsen_US
dc.subjectRadiationen_US
dc.subjectTreatment resistanceen_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.subjectSDG-09: Industry, innovation and infrastructureen_US
dc.titleIonising radiation exposure-induced regulation of selected biomarkers and their impact in cancer and treatmenten_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Mzizi_Ionising_2024.pdf
Size:
15.52 MB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: